1-9 of 9
Hui-qiang Huang, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preliminary Results from a Multicenter, Single-Arm, Phase 2 Study of CS1001, an Anti-Programmed Death-Ligand 1 (PD-L1) Human Monoclonal Antibody (mAb), in Patients (pts) with Relapsed or Refractory Extranodal Natural Killer/T Cell Lymphoma (rr-ENKTL)

Hui-qiang Huang, MD PhD, Rong Tao, MD PhD, Liqun Zou, Hong Cen, MD PhD, Ye Guo, MD PhD, Yunhong Huang, MD PhD, Wenbin Qian, MD PhD, Liling Zhang, MD PhD, Hui Zhou, MD PhD, Yu Yang, MD PhD, Haiyan Yang, Dan Zhu, Teng Fang, PhD, Hangjun Dai, Yueling Wang, Jianxin Yang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2833.
https://doi.org/10.1182/blood-2019-121865
Published: 2019
Journal Articles

Thalidomide Maintenance in Patients with Diffuse Large B-Cell Lymphoma after Autologous Stem Cell Transplantation: Single-Center Experience

Hui-qiang Huang, MD PhD, Bai Bing, Wang Xiaoxiao, Gao Yan, Pengfei Li, Rong Qixiang, Li-qin Ping
Journal: Blood
Blood (2018) 132 (Supplement 1): 1714.
https://doi.org/10.1182/blood-2018-99-111819
Published: 2018
Journal Articles

P-Gemox Regimen(Pegaspargase, Gemcitabine, oxaliplatin) for Extranodal Natural Killer Cell Lymphoma: 10 Years' Real-World Clinical Experience from China

Gao Yan, Hui-qiang Huang, MD PhD, Wang Xiaoxiao, Bai Bing, Pengfei Li, Hui Zhou, Zhi-gang Peng, Xiao-yan Ke, Kai-yang Ding, Yu Yang, MD, Sha-dong Min, Yue-rong Shuang, Li Zhiming, Cai Qingqing, Bingzong Li, MDPhD, Wenqi Jiang
Journal: Blood
Blood (2018)
https://doi.org/10.1182/blood-2018-99-116551
Published: 2018
Journal Articles

The Therapeutic Response of Chidamide Was Associated with Elevated H3 Acetylation Level in Patients with Refractory/Relapsed Non-Hodgkin Lymphoma (R/R-NHL)

Hui-qiang Huang, MD PhD, Pengfei Li, Yan Gao, Bai Bing, Wang Xiaoxiao, Rong Qixiang, Su Li, Wenqi Jiang
Journal: Blood
Blood (2017) 130 (Supplement 1): 4080.
https://doi.org/10.1182/blood.V130.Suppl_1.4080.4080
Published: 2017
Journal Articles

Safety and Clinical Activity Of Crizotinib In Patients With ALK -Rearranged Hematologic Malignancies

Carlo Gambacorti-Passerini, MD, Keizo Horibe, MD, PhD, Fadi Braiteh, MD, CPI, Hui-qiang Huang, MD, PhD, Yuankai Shi, MD, PhD, Matthew H Taylor, MD, Nicoletta Brega, Jolanda Paolini, Paulina Selaru, Tae Min Kim, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4342.
https://doi.org/10.1182/blood.V122.21.4342.4342
Published: 2013
Journal Articles

IL-6 Promotes Cell Proliferation and Antiapoptosis Through Activation Of The JAK/STAT3 Pathway In Patients With NK/T - Cell Lymphoma and Correlates With Poor Treatmemt Outcome

Qichun Cai, M.D., Ph.D., Hui-qiang Huang, MD, PhD, Bing Bai, M.D., Ph.D., Suxia Lin, M.D., Ph.D., Yan Gao, M.D., Yi Xia, M.D., Ph.D., XiaoXiao Wang, M.D., Ph.D., Jiabin Lu
Journal: Blood
Blood (2013) 122 (21): 1758.
https://doi.org/10.1182/blood.V122.21.1758.1758
Published: 2013
Journal Articles

Efficacy and Safety Of Pegaspargase With Gemcitabine and Oxaliplatin In Patients With Treatment-naïve, Refractory Extranodal Natural Killer/T-Cell Lymphoma: A Single-Centre Experience

Yan Gao, M.D., Hui-qiang Huang, MD, PhD, Cai QiChun, XiaoXiao Wang, M.D., Ph.D., QinfQing Cai, Zhongjun Xia, MD, Bing Bai, Wei Zhao, Wenqi Jiang, MD, PhD, ZhongZhen Guan
Journal: Blood
Blood (2013) 122 (21): 642.
https://doi.org/10.1182/blood.V122.21.642.642
Published: 2013
Journal Articles

Novel Combination Of Lenalidomide-Rituximab Provides An Effective Bridge To Stem Cell Transplantation In Relapsed and/Or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphomas: A Single Center Experience

Qingqing Cai, MD, PhD, Yiming Chen, MD., PhD., Dehui Zou, Maria Badillo, BS, Shouhao Zhou, PhD, Liang Zhang, MD, PhD, Elyse R Lopez, Wenqi Jiang, MD, PhD, Hui-qiang Huang, MD, PhD, Tongyu Lin, MD, PhD, Michael Wang, MD
Journal: Blood
Blood (2013) 122 (21): 3056.
https://doi.org/10.1182/blood.V122.21.3056.3056
Published: 2013
Journal Articles

Long-Term Outcome of Gemcitabine, Vinorelbine, Liposomal-Doxorubicin (GVD) As Salvage Regimen for Patients with Previously Heavily Treated Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma

Hui-qiang Huang, MD, PhD, Bing Bai, Qingqing Cai, Xu-Bin Lin, MD, Xiao-Xiao Wang, Qi-Chun Cai
Journal: Blood
Blood (2011) 118 (21): 1609.
https://doi.org/10.1182/blood.V118.21.1609.1609
Published: 2011